| |
Home
> Archives > Additional
Archives > Art Olson |
| |
Art Olson
Dept of Molecular Biology
The Scripps Research Institute
La Jolla, CA 92093
olson@scripps.edu
http://www.scripps.edu/pub/olson-web/
Abstract:
We have developed a new computational approach to simulating the evolution
of drug resistance and screening drug candidates in silico for robustness
in the face of resistance mutations. The approach is based upon the
use of co-evolutonary algorithms to test and rank competing populations
of trial drugs and mutant drug targets [Rosen, 1999a]. We have been
using the extensive structural and clinical data on the HIV protease
system to test and validated the approach. Our first series of computations
used a simplified volume based measure of viral viability to allow
the virtual screening of millions of possible drugs against millions
of possible mutants[Rosen, 2000b]. Recent work has focused on more
detailed models for drug-target interactions to aid in our understanding
and prediction of clinical development of drug resistant strains.
We have been able to use our methods to "predict" the protease
active site mutations that have been observed in clinical isolates
from the FDA approved drug therapies, and to suggest structural modifications
to these drugs to make them more robust [Stoffler, 2001].
Our latest effort involves extending these approaches with a fully
detailed atomic model by using our AutoDock flexible drug docking
in a massively parallel computational environment. In collaboration
with Entropia, we have established an internet-based community (currently
over 20,000 individuals) who have donated their computers to run our
docking computations on HIV-protease drug screening (FightAids@Home).
With the orders of magnitude more computing power, we anticipate the
development of extended novel methodologies, as well as greatly improved
modeling results.
Rosin, C.D., Belew, R.K., Morris, G.M., Olson, A.J. (1999) Coevolutionary
analysis of resistance-evading peptidomimetic inhibitors of HIV-1
protease. Proc. Natl. Acad. Sci. USA 96:1369-1374.
Rosin, C., Belew, R., Walker, W., Morris, G., Olson, A., Goodsell,
D.S. (1999) Coevolution and subsite decomposition for the design of
resistance-evading HIV1 protease inhibitors. J. Mol. Biol. 287(1):77-92.
Stoffler, D., Sanner, M., Morris, G.M., Olson, A.J., Goodsell, D.
(2001) Evading HIV-1 protease drug resistance. Submitted, J. Mol.
Biol. |